Results 51 to 60 of about 1,206 (76)
BMC Infectious Diseases, 2009 Background In patients with chronic respiratory disease, Pneumocystis jirovecii (P. jirovecii) colonization is observed, and may influence disease progression and systemic inflammation.
Shimizu Yasuo +6 more
doaj +1 more source
Transplant Infectious Disease, EarlyView.Use of POCtmPCR with noninvasive samples (NPS and sputum) in LTx recipients with viral LRTI are a viable alternative to invasive BAL sampling, ABSTRACT Background Respiratory tract infections (RTIs) are a leading cause of morbidity and mortality following lung transplantation (LTx).
Susanne Simon +4 more
wiley +1 more source
A case of Talaromyces marneffei infection that required differentiation from Pneumocystis pneumonia
IDCases, 2023 We report a case of Talaromyces marneffei fungemia in a patient with HIV infection with a history of travelling to southern China. At first, Pneumocystis pneumonia was considered in this case because chest CT images showed typical ground-glass opacity ...
Mieko Tokano +8 more
doaj
Clinical Case Reports, Volume 13, Issue 6, June 2025.ABSTRACT Erythema nodosum (EN) can be an atypical manifestation of rheumatoid arthritis (RA), as seen in this case of a 35‐year‐old woman initially misdiagnosed with cellulitis. Despite negative cultures and antibiotic treatment, further evaluation revealed elevated rheumatoid factor and anti‐CCP antibodies, confirming RA.
Laxman Wagle +3 more
wiley +1 more source
Respiratory Medicine Case Reports, 2018 Spontaneous pneumothorax is a rare complication of pneumocystis jirovecii pneumonia. We report a patient with pneumocystis jirovecii pneumonia and therapy-refractory, right-sided pneumothorax due to persistent air leak (PAL) despite prolonged chest tube ...
Stefanie Bader +4 more
doaj
Nanomaterials, 2020 Pneumocystis jirovecii is a fungus responsible for human Pneumocystis pneumonia, one of the most severe infections encountered in immunodepressed individuals.
Olalla Calvo-Lozano +7 more
doaj +1 more source
International Journal of Rheumatic Diseases, Volume 28, Issue 6, June 2025.ABSTRACT Objectives The aim of this study was to identify the risk factors for Pneumocystis jirovecii pneumonia (PCP) in patients with rheumatoid arthritis (RA) and to recommend appropriate disease‐modifying antirheumatic drug (DMARD) selection for those at high risk of developing PCP. Methods We conducted a retrospective review of patients with RA who
Yuki Hara +7 more
wiley +1 more source
Asia-Pacific Journal of Clinical Oncology, Volume 21, Issue 3, Page 319-327, June 2025.Age and history of lung radiotherapy are overlooked risk factors for Pneumocystis jirovecii pneumonia (PCP) in cancer patients. Prophylaxis appeared to be fully effective. 21‐day mortality rate in the PCP group was 35.4%. Hematologic malignancy and lung cancer patients are at highest risk for mortality.
S. Chatterji +6 more
wiley +1 more source
Toward a humanized mouse model of Pneumocystis pneumonia
JCI Insight, 2021 Pneumocystis is an important opportunistic fungus that causes pneumonia in children and immunocompromised individuals. Recent genomic data show that divergence of major surface glycoproteins may confer speciation and host range selectivity.
Guixiang Dai +4 more
doaj +1 more source
HIV Medicine, Volume 26, Issue 6, Page 839-848, June 2025.Abstract Background Immune reconstitution inflammatory syndrome (IRIS) can occur in patients with HIV after commencing antiretroviral therapy. Tuberculosis–IRIS is the most common, and Pneumocystis jirovecii pneumonia (PJP)–IRIS accounts for only 2.7%–4% of IRIS cases.
Natasha Marcella Vaselli +3 more
wiley +1 more source